Mabpharm Limited

HKEX:2181.HK

0.305 (HKD) • At close September 13, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q22017 Q12016 Q4
Omzet 21.57121.57122.0122.0113.53613.53614.42414.4240.8180.81840.62340.62300005.2685.2681.771.776.886.885.0845.0840000
Kosten van de omzet 2.8632.8633.0993.0992.1612.1615.5275.5270.0040.0048.3848.3840000000000000000
Brutowinst 18.70818.70818.91118.91111.37511.3758.8978.8970.8140.81432.23932.23900005.2685.2681.771.776.886.885.0845.0840000
Brutowinstmarge 0.8670.8670.8590.8590.840.840.6170.6170.9950.9950.7940.7940000111111110000
Onderzoek- en ontwikkelingskosten 31.84231.84229.76429.76434.95834.95838.99538.99550.05950.05981.72881.72829.79529.79530.41430.41437.74337.74329.35229.35231.33131.33113.16113.16122.2465.4085.4085.408
Algemene en administratieve kosten 28.75328.75323.57723.57721.36321.36323.91623.91623.43923.43921.87821.87817.52717.52715.37115.37117.53317.53313.93313.93313.613.65.9935.9938.5911.2171.2171.217
Verkoop- en marketingkosten 10.9410.9413.52313.5236.4756.4757.6327.6324.7124.7120000000.0030.0030.0090.0091.1141.1140.3590.3590000
Verkoop-, algemene en administratieve kosten 39.58739.58737.41937.41927.89627.89631.54831.54828.1528.1521.87821.87817.52717.52715.37115.37117.53517.53513.94113.94114.71314.7136.3516.3518.5911.2171.2171.217
Overige kosten 000000000000000000-104.876-104.876-104.8760-61.646-61.646-61.646-13.559-13.559-13.559
Bedrijfskosten 70.91270.91266.67266.67256.40756.40765.87165.87173.99373.993104.707104.70765.20665.20629.86929.86948.748.757.71757.71760.38960.38925.69725.697-30.809-6.934-6.934-6.934
Bedrijfsresultaat -52.721-52.721-48.272-48.272-51.479-51.479-61.647-61.647-77.395-77.395-71.367-71.367-47.322-47.322-45.785-45.785-52.074-52.074-41.523-41.523-42.667-42.667-17.179-17.179-30.809-6.934-6.934-6.934
Bedrijfsresultaat ratio -2.444-2.444-2.193-2.193-3.803-3.803-4.274-4.274-94.614-94.614-1.757-1.7570000-9.886-9.886-23.466-23.466-6.202-6.202-3.379-3.3790000
Totaal overige inkomsten en kosten netto -1.958-1.958-1.728-1.7284.4744.4743.2423.2424.1034.103-1.214-1.214-17.9-17.918.69118.6918.658.65-16.318-16.318-12.077-12.077-4.374-4.374-7.339-4.993-4.993-4.993
Inkomen voor belasting -54.679-54.679-50-50-47.005-47.005-58.405-58.405-73.292-73.292-72.581-72.581-65.222-65.222-27.094-27.094-43.424-43.424-57.841-57.841-54.744-54.744-21.553-21.553-38.148-11.927-11.927-11.927
Inkomen voor belasting ratio -2.535-2.535-2.272-2.272-3.473-3.473-4.049-4.049-89.598-89.598-1.787-1.7870000-8.244-8.244-32.687-32.687-7.957-7.957-4.239-4.2390000
Belastingkosten 00-00-000000000000001.9241.9241.4171.417-0.709-0.709-0.7090.8320.8320.832
Nettowinst -54.679-54.679-50-50-47.005-47.005-58.405-58.405-73.292-73.292-72.581-72.581-65.222-65.222-27.094-27.094-43.424-43.424-57.841-57.841-48.409-48.409-14.033-14.033-37.44-12.759-12.759-12.759
Nettowinstmarge -2.535-2.535-2.272-2.272-3.473-3.473-4.049-4.049-89.598-89.598-1.787-1.7870000-8.244-8.244-32.687-32.687-7.037-7.037-2.76-2.760000
WPA (Winst Per Aandeel) -0.015-0.015-0.012-0.012-0.011-0.011-0.015-0.015-0.018-0.018-0.02-0.02-0.016-0.016-0.007-0.007-0.011-0.011-0.017-0.017-0.018-0.018-0.01-0.01-0.009-0.003-0.003-0.003
Verwaterde WPA -0.013-0.013-0.012-0.012-0.011-0.011-0.014-0.014-0.018-0.018-0.018-0.018-0.016-0.016-0.007-0.007-0.011-0.011-0.017-0.017-0.016-0.016-0.01-0.01-0.009-0.003-0.003-0.003
EBITDA -38.549-38.549-36.515-36.515-40.682-40.682-51.157-51.157-67.067-67.067-64.324-64.324-43.055-43.055-41.912-41.912-48.372-48.372-37.952-37.952-39.04-39.04-14.948-14.948-27.88-4.414-4.414-4.414
EBITDA ratio -1.787-1.787-1.659-1.659-3.006-3.006-3.547-3.547-81.99-81.99-1.583-1.5830000-9.183-9.183-21.448-21.448-5.675-5.675-2.94-2.940000